| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-06 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.2 | 3e-05 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.14 | 3e-05 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.25 | 6e-05 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.15 | 7e-05 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.13 | 7e-05 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0002 |